- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 277/44 - Acylated amino or imino radicals
Patent holdings for IPC class C07D 277/44
Total number of patents in this class: 85
10-year publication summary
|
5
|
4
|
8
|
4
|
3
|
4
|
2
|
2
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
5 |
| Stemsynergy Therapeutics, Inc. | 18 |
4 |
| Glaxo Group Limited | 4281 |
3 |
| Syngenta Participations AG | 3032 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 737 |
2 |
| The Johns Hopkins University | 5533 |
2 |
| ARIAD Pharmaceuticals, Inc. | 83 |
2 |
| Astellas Pharma Inc. | 1125 |
2 |
| Nippon Soda Co., Ltd. | 883 |
2 |
| University Health Network | 1018 |
2 |
| Novartis AG | 11254 |
1 |
| Bristol-myers Squibb Company | 4863 |
1 |
| Genentech, Inc. | 3869 |
1 |
| Massachusetts Institute of Technology | 9913 |
1 |
| DSM IP Assets B.V. | 5802 |
1 |
| Abbvie Inc. | 1782 |
1 |
| Takeda Pharmaceutical Company Limited | 2943 |
1 |
| Vertex Pharmaceuticals Incorporated | 1568 |
1 |
| Adeka Corporation | 1342 |
1 |
| Other owners | 43 |